Platelet activating factor (PAF) is derived predominantly from membrane bound phosphatidylcholine. It is rapidly synthesised after activation of inflammatory cellsl-4 and has been found in high concentrations in colonic mucosal biopsy tissue from patients with ulcerative colitis.5 PAF exhibits a variety of effects, in particular on inflammatory cells. These effects are mediated via specific plasma membrane receptors67 and include modulation ofthe immune response by stimulating the production of other mediators, vasodilation, increased vascular permeability, and the promotion of chemotaxis.8-12 PAF also stimulates mucosal chloride secretion and inhibits sodium chloride absorption,13 so it could contribute to the production of diarrhoea in ulcerative colitis. During the inflammatory response, however, many mediators are released and it is difficult to establish which is responsible for liberating PAF and which, if any, is responsible for mediating its effect on mucosal function.
Platelet activating factor (PAF) is derived predominantly from membrane bound phosphatidylcholine. It is rapidly synthesised after activation of inflammatory cellsl-4 and has been found in high concentrations in colonic mucosal biopsy tissue from patients with ulcerative colitis.5 PAF exhibits a variety of effects, in particular on inflammatory cells. These effects are mediated via specific plasma membrane receptors67 and include modulation ofthe immune response by stimulating the production of other mediators, vasodilation, increased vascular permeability, and the promotion of chemotaxis.8-12 PAF also stimulates mucosal chloride secretion and inhibits sodium chloride absorption,13 so it could contribute to the production of diarrhoea in ulcerative colitis. During the inflammatory response, however, many mediators are released and it is difficult to establish which is responsible for liberating PAF and which, if any, is responsible for mediating its effect on mucosal function.
We previously reported that culture medium from inflamed colitic mucosa evoked a secretory response that was partly mediated by arachidonic acid metabolites -that is prostaglandins and leukotrienes.14 Because inhibitors of these arachidonic acid metabolites failed to block all of the secretory effect, we postulated that another phospholipid derivative, PAF, might account for the remaining secretory response. To test this hypothesis we have investigated factors that influence the release of PAF from human colonic mucosa, examined its effect on colonic secretion and considered whether this effect is mediated by prostaglandins and leukotrienes.
Methods

PATIENT DETAILS
Mucosal biopsy specimens were taken from 40 patients during colonoscopy. All had undergone bowel preparation consisting of a three day low residue diet and, one day before the examination, a combination of X prep (purified senna extract; 1 mllkg body weight) and 10% mannitol (500 ml) modified according to the patients' symptoms.
Twenty eight patients (16 M, 12 F, median age 38-3 years) with active proctosigmoiditis (grade 3/4) had biopsy specimens taken from inflamed rectal mucosa and also from uninflamed, 'quiescent' proximal mucosa from the ascending colon. At the time of colonoscopy nine patients were taking mesalazine (400 mg three times daily), six prednisolone (5 to 15 mg once daily), and 10 topical steroids. Twelve patients (6 M, 6 F, median age 36.8 years), who were being investigated for altered bowel habit, had biopsy specimens taken from endoscopically and histologically normal colonic mucosa. To minimise tissue trauma all biopsies were taken with non-spiked forceps.
BIOPSY CULTURE
After removal, mucosal biopsy specimens were immediately placed in transport medium (LI 5, with added penicillin G 100 units/ml and streptomycin sulphate 100 ,ug/ml); transferred to the laboratory; gently washed three times in the Li 5 medium; and carefully blotted, weighed, and placed in a 4 cm culture dish containing 1 ml of culture medium (CMRL 1066, plus glucose 5 ,ug/ml, methionine 1 pum/ml, Tris buffer 20 mM, glutamine 3 mM, P-retinyl acetate 1 ,ug/ml, penicillin G 100 units/ml, streptomycin sulphate 100 ,ug/ml, gentamicin 50 ,ug/ml, and amphotericin P3 0.25 ,ug/ml).
Isolated biopsy culture Biopsy specimens from inflamed, quiescent, and normal mucosa were cultured to assess PAF release.
To investigate the effect of other compounds on PAF release, specimens were cultured in the presence of one of the following: * PAF receptor antagonist (CV6209) at a final concentration of 10-5 M. * Potential stimulators of PAF releasebradykinin, 5-hydroxytryptamine, or histamine was added to the culture medium, producing final concentrations ranging from 10-10 to 10-4 M. Their respective receptor antagonists des arg leu bradykinin (10-8 M), ketanserin , and combined chlorpheniramine maleate and ranitidine (10-6 M) Performance characteristics of these assays in our laboratory were as follows: intra-assay and interassay coefficient of variation PGE2 5%, LTD4 8%; recovery PGE2 90%, LTD4 94%; sensitivity PGE2 1.9 pg/ml, LTD4 4.6 pg/ml. Cross reactivity: PGE2 (non-E prostaglandin) <0.4%,16 LTD4 (non-sulphidopeptide leukotrienes) <0 001%.17 TRANSPORT 
STUDIES
Rat distal colon preparation Unfasted male Sprague-Dawley rats were killed and the distal colon was removed immediately and bathed in oxygenated buffer. A modified in vitro technique based on that of Ussing and Zerahn was used.'8 Muscle layers were stripped and the two most distal pieces of mucosa were mounted as sheets between Perspex flux chambers, with a surface area of 0.64 cm2 (VT Plastics Ltd, Warrington, UK). Spontaneous, basal transmucosal potential difference (PD) was measured on a high impedance digital voltmeter attached via fine tipped electrode bridges (3 M KCl in 3°/O agar). Short circuit current (Isc) was delivered via 1 M NaCl in 1% agar bridges, by silver/silver chloride electrodes. The electrodes were connected to a voltage clamp for automatic short circuiting. The clamp was corrected for fluid resistance between the PD and sensing bridges. Tissue conductance and resistance were calculated from the PD and Isc according to Ohm's law.
In this mucosal preparation, a rise in Isc and PD is associated with secretion of chloride ions and we have used this rise in electrical parameters as a proxy for anion secretion.
Both surfaces of each mucosal sheet were bathed with 5 ml of isotonic buffer containing: Na 146 mM, K4.2 mM, Cl 125.8 mM, HCO3 26.6 mM, H2P04 0'2 mM, HPO4 1.2 mM, Ca 1.2 mM, Mg 1.2 mM, and glucose 10 mM, at pH 7.4. The bathing media were maintained at a constant temperature of 37°C and stirred and oxygenated via a bubble lift system using 95% 02/5% CO2.
The following compounds were added to the fluid bathing either the basolateral or the apical aspect of the rat colonic mucosal preparation after electrical stability had been reached (usually 60 minutes). * PAF: this was added to the fluid bathing stripped rat distal colon to produce a range of concentrations from 10-10 to 10-4 M. Changes in PD, Isc, and resistance were recorded. * PAF receptor antagonist CV6209: this was added to the bathing fluid at a final concentration of 10-6 M, immediately before PAF at concentrations which had evoked a maximal and half maximal electrical response. * Combined indomethacin and ICI 207968: this combination (10-5 M) was added to block production of prostaglandin and leukotrienes immediately before the addition of PAF (at concentrations which had evoked a maximal and half maximal electrical response). * Culture medium: culture medium (100 ,ul) was added to the basolateral aspect of rat distal colonic mucosa and electrical parameters, as described above, were measured. This process was repeated using medium from biopsy specimens cultured in the presence of factors influencing the release of PAF as detailed above. (Fig 1) . (Fig 1) . * (1) Histamine: Histamine, ranging from 10-10 to 10-4 M, did not significantly influence PAF production by inflamed mucosa (Fig 2) . Histamine did not stimulate PAF production by either quiescent colitic or normal tissue.
CHEMICALS
(2) Histamine receptor antagonists: basal PAF production by inflamed tissue was not significantly influenced by histamine receptor antagonists (795 (45) v 763 (49), respectively, NS) (Fig 1) . * (1) 5-Hydroxytryptamine: this stimulated PAF production by inflamed mucosa (maximal response at 10-6 M 923 (58) v basal 795 (45), p<001) and by quiescent colitic (169 (18) v basal 0), but not normal, tissue (Fig 2) .
(2) 5-Hydroxytryptamine receptor antagonist, ketanserin attenuated PAF release by inflamed mucosa (563) (21) v 795 (45): p<0-005) (Fig 1) . * Combined treatment with bradykinin, histamine, and 5-hydroxytryptamine evoked a 59% increase in PAF release by inflamed tissue when compared with basal release (1260 (93) v 795 (45), p<0005) (Fig 1) . * Cyclooxygenase and lipoxygenase inhibitors: the basal production of PAF by inflamed 5HT=5-hydroxytyptamine. S=combined Basolateral addition of cyclooxygenase and lipoxygenase inhibitors significantly attenuated the short circuit response to platelet activating factor at maximal and half maximal concentrations (71-4 (6.9) v 18.1 (2.2); 35.7 (3.5) respectively, p<0005, Fig 6) .
Effect of culture medium on electrical response Medium from inflamed tissue, applied to the basolateral. half chamber, generated a significantly greater Isc than medium from either quiescent or control tissue (32-4 (2.7) v 7-8 (1.1): 7-1 (0-9), jiAcm-2, p<0-001). Freshly prepared culture medium did not evoke any change in baseline electrical activity (Fig 7) . Effect of culture medium from tissue treated with combined cyclooxygenase and lipoxygenase inhibitors. There was no significant difference between the Isc responses evoked by culture media from normal tissue that were either Control Quiescent (Fig 7) . Culture medium from inflamed mucosa, after this combined treatment, produced a significantly lower Isc response than medium from untreated mucosa (9.9 (0.9) v 32.4 (2.9) puAcm-2, p<O005).
Effect of culture medium from tissue treated with phospholipase A2 inhibitors. Culture medium from normal mucosa treated with either mepacrine or hydrocortisone produced an Isc which was significantly lower than medium p<OOl) (Fig 7) . Similar results were obtained with culture medium from quiescent tissue. Medium from inflamed tissue treated with ned cyclooxyge-either mepacrine or hydrocortisone signifion (7-1 (0.9) v cantly attenuated the short circuit response Similar results when compared with medium from either from quiescent untreated mucosa or mucosa cultured in the ,posed to com-presence of combined cyclooxygenase and ,ygenase inhibi-lipoxygenase inhibition (6.3 (1.2): 5.1 (0.9) v from inflamed 32-4 (2.7): 13.6 (1P9), puAcm-2 respectively, however, pro-p<0OO1). when compared Lflamed mucosa n-2, p<0005). Discussion ssue treated with In these studies we have shown that inflamed )9 did not influ-mucosa but not quiescent mucosa from cal activity seen patients with ulcerative colitis releases PAF ial or quiescent into culture medium. Furthermore, quiescent medium from mucosa releases PAF when stimulated with presence of CV bradykinin, 5-hydroxytryptamine, and colower Isc than cultured inflamed mucosa. Mucosa from lamed mucosa normal, 'control' patients, however, did not produce any detectable PAF. Culture medium Inflamed t from any of the tissues will evoke an electrical response in stripped rat colon.
Inflamed tissue liberated PAF in greater * | g quantities than previously reported,5 and this In cultured colonic tissue, PAF stimulated lipase A2 inhibitors, a concentration dependent rise in both )rtisone, significantly PGE2 and LTD4: similarly, PAF has been of PAF and other shown to augment the production of LTB4 ,14 Considering the and 5 HETE.20 22 The threshold for a odulatory activities of response in colonic tissue was in the range of t mepacrine is only a 10-8 M-10-9 M, with a maximum stimula-)r, it was surprising to tory effect at a PAF concentration of 10-5 M, and hydrocortisone considerably higher than the measured conresponse evoked by centration (828 (74) release. Although PAF may upregulate the activity of both cyclooxygenase and lipoxygenase, it seems likely that the PAF stimulated increase in both intracellular calcium'2 and eicosanoid output is mediated by phospholipase C.
Although PAF stimulated eicosanoid release, these compounds did not account for all of its secretory action. Inhibition of phospholipase A2 derived secretagogues with either mepacrine or hydrocortisone reduced the culture medium evoked electrical response by approximately 81%, of which eicosanoids contributed nearly 60% and presumably PAF the remainder. There is, however, some disparity between this presumed secretory influence attributed to PAF (21%), and the actual response that it evoked (46%). Furthermore, medium from inflamed tissue treated with combined inhibition of cyclooxygenase, lipoxygenase, and PAF receptors attenuated the Isc response by 69%, of which eicosanoids accounted for 58%. This disparity between the presumed and actual secretory response evoked by PAF indicates that much of this PAF response is mediated by eicosanoids. Although platelet activating factor and eicosanoids account for 69% of the secretory response evoked by culture medium, a further 12% is attributed to compounds that are antagonised by both mepacrine and hydrocortisone and it is likely that phospholipase C derivatives are involved. The residual medium evoked electrical response is presumably a reflection of a variety of cytokines and compounds released by the enteric nervous system.
It is interesting to speculate that as PAF accounted for, at most, 46% of the culture medium secretory effect, any therapeutic attempts to block PAF release/receptors in patients with ulcerative colitis will have a limited effect on their symptoms. Inhibition of one individual phospholipid derivative, or even one group of phospholipid derivatives is highly unlikely to produce any therapeutic benefit -as exemplified by the failure of non-steroidal antiinflammatory drugs in the treatment of ulcerative Colitis.'4 [23] [24] [25] In conclusion, we have shown not only that PAF stimulates colonic secretion, accounting for 46% of the secretory response evoked by culture medium from colitic tissue, but also that its actions are mediated, predominantly by eicosanoids.
